ExpreS2ion Biotech Holding AB
A clinical-stage biotech company developing vaccines for cancer and infectious diseases.
EXPRS2 | ST
Overview
Corporate Details
- ISIN(s):
- SE0008348262 (+4 more)
- LEI:
- 549300FJK50P1ORYJC45
- Country:
- Sweden
- Address:
- C/O Mindpark, 252 25 Helsingborg
- Website:
- https://www.expres2ionbio.com/
- Sector:
- Manufacturing
Description
ExpreS2ion Biotech Holding AB is a clinical-stage biotechnology company that develops innovative vaccines and biologics to address unmet medical needs. The company utilizes its proprietary protein expression platform, ExpreS2, to create a pipeline of vaccine candidates. Its development portfolio focuses on both therapeutic cancer vaccines (immunotherapies) and prophylactic vaccines for major infectious diseases, including malaria and breast cancer. ExpreS2ion advances its programs through strategic collaborations and licensing agreements with partners, such as the Serum Institute of India for its novel blood-stage malaria vaccine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ExpreS2ion Biotech Holding AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ExpreS2ion Biotech Holding AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ExpreS2ion Biotech Holding AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
